Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70)

Synonyms: Anti-Human CD70 Recombinant Antibody

Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) is a humanized monoclonal antibody that specifically recognizes and binds to CD70 molecular. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells and shows inhibitory efficacy against Burkitt’s lymphoma. MW : 150 kDa.

Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) is a humanized monoclonal antibody that specifically recognizes and binds to CD70 molecular. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells and shows inhibitory efficacy against Burkitt’s lymphoma. MW : 150 kDa.

Product Details

CAS No. 1165740-62-4
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) | Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) supplier | purchase Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) | Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) cost | Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) manufacturer | order Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) | Vorsetuzumab (Anti-TNFSF7 / CD27L / CD70) distributor